The use of corticosteroids in syntomathic asthma in childhood

Area of Science:

• Pediatric Pulmonology
• Pharmacology
• Clinical Practice Guidelines

Background:

• Corticosteroids (CS) are a cornerstone in managing childhood asthma and wheezing illnesses.
• Inhaled corticosteroids (ICS) are first-line therapy for persistent childhood asthma.
• Concerns exist regarding the overuse of ICS in children who may not have asthma or have alternative wheezing disorders.

Purpose of the Study:

• To review the evidence supporting the use of corticosteroids in pediatric wheezing disorders.
• To evaluate current prescribing practices for corticosteroids in children with wheezing conditions.
• To assess the benefits and risks of corticosteroid use in common pediatric wheezing illnesses.

Main Methods:

• Systematic literature review of studies on corticosteroid use in pediatric wheezing.
• Analysis of clinical guidelines and prescribing data.
• Evidence synthesis on efficacy and safety in various pediatric wheezing conditions.

Main Results:

• Corticosteroids offer significant benefits for children with persistent asthma, reducing the need for oral steroids.
• Evidence suggests ICS are prescribed to a broader population than indicated, including children with non-asthmatic wheezing.
• Variability in prescribing practices highlights potential for both under- and over-treatment.

Conclusions:

• While essential for asthma, corticosteroid use in pediatric wheezing requires careful patient selection.
• Optimizing prescribing practices is crucial to maximize benefits and minimize risks associated with corticosteroid therapy.
• Further research is needed to refine diagnostic criteria and treatment algorithms for pediatric wheezing disorders.